KRd Consolidation in Myeloma Patients With a Positive PET-CT After Standard First Line Treatment. A Phase II Study
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms CONPET
- 15 Sep 2019 Planned primary completion date changed from 1 Mar 2020 to 1 Sep 2020.
- 09 Aug 2018 Status changed from not yet recruiting to recruiting.
- 03 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.